the speculators article today, page-10

Ptolemy

Fair comment .. I recall other tech stocks like GDP that struggled for years to sell the world the best ever blood fractionation technology .. never really got there as it required massive re-investment by the fractionators in new equipment. I am a long-term TZL supporter and current shareholder but I do hold some of your concerns .. hence my anxiety on this forum with the lack of concrete announcements about sales or agreements for Intevia. Acment and TZL are convinced that the market is up to US$250m per year ...but as yet we haven't seen any significant sales agreement.

Hopefully the promised and expected shareholder update will soon put us in the picture. Not being negative just realistic!

H